NCT06846606
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06846606
Title Phase 1 Study of AUTX-703 in Relapsed/Refractory AML and MDS
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Auron Therapeutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope National Medical Center RECRUITING Duarte California 91010 United States Details
H Lee Moffitt Cancer Center and Research Institute RECRUITING Tampa Florida 33612 United States Details
Roswell Park Comprehensive Cancer Center RECRUITING Buffalo New York 14203 United States Details
Memorial Sloan Kettering Cancer Center RECRUITING New York New York 10021 United States Details
University of North Carolina at Chapel Hill RECRUITING Chapel Hill North Carolina 27514 United States Details
Ohio State University, The James Comprehensive Cancer RECRUITING Columbus Ohio 43210 United States Details
UPENN Perelman Center for Advanced Medicine RECRUITING Philadelphia Pennsylvania 19104 United States Details
Sarah Cannon Center for Blood Cancer at TriStar Centennia RECRUITING Nashville Tennessee 37203 United States Details
University of Texas MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field